Clinical Trial Update: Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating immunotoxin therapy before and after surgery for recurrent malignant glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Immunotoxin therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED